Concepedia

Author

Hitt Sharma

Serum Institute of India (India)ORCID

Also Known As

H. Sharma, H.J. Sharma, Hitt J Sharma, Hitt J. Sharma, Hitt Sharma, Sharma, Hitt J

46

Publications

394

Citations

13

H-Index

33

Concepts

All Affiliations

Serum Institute of India (India)Veterinary Biological and Research InstituteMaulana Azad Medical CollegeBharati Vidyapeeth Deemed UniversityAtal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital
HS

About

Hitt Sharma is an author at Serum Institute of India (India) specializing in medicine, vaccination, and vaccine development.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

159

2

Immunology

4

4

78

3

Epidemiology

2

2

53

4

Public Health

1

1

35

5

Surgical Oncology

1

1

15

Hitt Sharma

×

15

Publications

329

Citations

13

H-Index

YearCitations

Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial

Hitt Sharma, Sameer Parekh, Pramod Pujari,

The Lancet Oncology

2023

35

Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy

Cyrill A. Rentsch, Piet Bosshard, G. Mayor,

OncoImmunology

2020

31

VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study

Alexandra M Blossey, Sina Brückner, Marcus May,

Clinical Infectious Diseases

2022

31

Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India

Hitt Sharma, V S Padbidri, Subhash V. Kapre,

The Journal of Infection in Developing Countries

2011

30

Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children

Hitt Sharma, Sangita Yadav, Sanjay Lalwani,

Human Vaccines

2011

29

A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants

Hitt Sharma, Sangita Yadav, Sanjay Lalwani,

Vaccine

2011

27

Sero-Surveillance to assess immunity to rubella and assessment of immunogenicity and safety of a single dose of rubella vaccine in school girls

Hitt Sharma, Sunil Chowdhari, TilakRaj Raina,

Indian Journal of Community Medicine

2010

21

An immunogenicity, safety and post-marketing surveillance of a novel adsorbed human diploid cell rabies vaccine (Rabivax<sup>®</sup>) in Indian subjects

Mysore Kalappa Sudarshan, Subodh Bhardwaj, B J Mahendra,

Human Vaccines

2008

20

Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine

Hitt Sharma, Sangeeta Yadav, Sanjay Lalwani,

Vaccine

2012

19

Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process

Hitt Sharma, Vishwanath Patil, Sanjay Lalwani,

Vaccine

2011

18

Page 1